These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2981524)

  • 21. [Effects of pepstatin A on neutrophils; cross-deactivation with FMLP].
    Muniain MA; Pozuelo F; Pérez-Venegas JJ; Romero-Tabares A; Rodríguez-Hornillo MC; Garrido M
    Rev Esp Fisiol; 1985 Mar; 41(1):125-31. PubMed ID: 2988085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C3a-induced lysosomal enzyme secretion from human neutrophils: lack of inhibition by f met-leu-phe antagonists and inhibition by arachidonic acid antagonists.
    Showell HJ; Glovsky MM; Ward PA
    Int Arch Allergy Appl Immunol; 1982; 67(3):227-32. PubMed ID: 6800960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides.
    Totti N; McCusker KT; Campbell EJ; Griffin GL; Senior RM
    Science; 1984 Jan; 223(4632):169-71. PubMed ID: 6318317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of neutrophil superoxide production by fanetizole.
    Styrt B; Rocklin RE; Klempner MS
    Inflammation; 1985 Sep; 9(3):233-44. PubMed ID: 2995253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation.
    Kocan GP; Partis RA; Mueller RA; Smith WG; Nakao A
    Biochem Pharmacol; 1994 Mar; 47(6):1029-37. PubMed ID: 8147901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils.
    Simchowitz L; Atkinson JP; Spilberg I
    J Clin Invest; 1980 Oct; 66(4):736-47. PubMed ID: 6252250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of recombinant human granulocyte/macrophage colony-stimulating factor on neutrophil superoxide production.
    Schultz RM
    Immunopharmacol Immunotoxicol; 1991; 13(1-2):183-98. PubMed ID: 1663143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modifications of the amide bond at position 3 in fMLP analogs select neutrophil functions.
    Spisani S; Breveglieri A; Fabbri E; Vertuani G; Rizzuti O; Cavicchioni G
    Pept Res; 1996; 9(6):279-82. PubMed ID: 9048420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The releasability of lysosomal enzymes from neutrophil leukocytes in patients with rheumatoid arthritis.
    Marinò I; Columbo M; Marone G
    Clin Exp Rheumatol; 1996; 14(4):387-94. PubMed ID: 8871837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of neutrophil-reduced pyridine nucleotide content following stimulation with phorbol myristate acetate and chemotactic factors.
    Van Epps DE; Bender JG; Steinkamp JA; Chenoweth DE
    J Leukoc Biol; 1985 Nov; 38(5):587-601. PubMed ID: 2995525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of trifluoperazine on human neutrophil function.
    Smith RJ; Bowman BJ; Iden SS
    Immunology; 1981 Dec; 44(4):677-84. PubMed ID: 6274792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release.
    Ogawa H; Kunkel SL; Fantone JC; Ward PA
    Am J Pathol; 1981 Nov; 105(2):149-55. PubMed ID: 7294162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical, metabolic and morphological characteristics of human neutrophil activation with pepstatin A.
    Smith RJ; Bowman BJ; Iden SS; Kolaja GJ; Wiser SK
    Immunology; 1983 Jun; 49(2):367-77. PubMed ID: 6303951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Actin assembly and regulation of neutrophil function: effects of cytochalasin B and tetracaine on chemotactic peptide-induced O2- production and degranulation.
    Bengtsson T; Dahlgren C; Stendahl O; Andersson T
    J Leukoc Biol; 1991 Mar; 49(3):236-44. PubMed ID: 1847714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface contact inhibits neutrophil superoxide generation induced by soluble stimuli.
    Hoffstein ST; Gennaro DE; Manzi RM
    Lab Invest; 1985 May; 52(5):515-22. PubMed ID: 2985869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leucocyte superoxide production by chloroquine and hydroxychloroquine.
    Hurst NP; French JK; Gorjatschko L; Betts WH
    Ann Rheum Dis; 1987 Oct; 46(10):750-6. PubMed ID: 2825613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of in vitro neutrophil responses to chemotactic factors by piroxicam.
    Tanaka K; Kanaoka K; Egawa M; Abe N; Watanabe I; Hirai S
    Jpn J Pharmacol; 1984 Jun; 35(2):181-91. PubMed ID: 6611436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of platelet-activating factor on superoxide anion production in human eosinophils and neutrophils.
    Mabuchi K; Sugiura T; Ojima-Uchiyama A; Masuzawa Y; Waku K
    Biochem Int; 1992 May; 26(6):1105-13. PubMed ID: 1321621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.